Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection

참고문헌 (72)

1. "Cancer" (2021)[URL]
2. "National Cancer Screening Program" (2016)[URL]
3. Smith, R. A., "Cancer screening in the United States, 2019 : a review of current American Cancer Society guidelines and current issues in cancer screening", CA Cancer J. Clin, 69, pp.184~210 (2019)
4. Crosby, D., "Early detection of cancer", Science, 375, pp.eaay9040~ (2022)
5. Gao, Q., "Circulating cell-free DNA for cancer early detection", Innovation, 3, pp.100259~ (2022)
6. Alix-Panabières, C., "Liquid biopsy : from discovery to clinical application", Cancer Discov, 11, pp.858~873 (2021)
7. Chen, G., "Integrative analysis of multi-omics data for liquid biopsy", Br. J. Cancer (2022)[DOI]
8. In’t Veld, S. G. J. G., "Detection and localization of early-and late-stage cancers using platelet RNA", Cancer Cell, 40, pp.999~1009 (2022)
9. Lennon, A. M., "Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention", Science, 369, pp.eabb9601~ (2020)
10. Keller, L., "Clinical relevance of blood-based ctDNA analysis : mutation detection and beyond", Br. J. Cancer, 124, pp.345~358 (2021)
11. Krebs, M. G., "Practical considerations for the use of circulating tumor DNA in the treatment of patients with cancer", JAMA Oncol, 8, pp.1830~ (2022)
12. Moser, T., "Bridging biological cfDNA features and machine learning approaches", Trends Genet (2023)[DOI]
13. Cisneros-Villanueva, M., "Cell-free DNA analysis in current cancer clinical trials : a review", Br. J. Cancer, 126, pp.391~400 (2022)
14. Mio, C., "Challenges in promoter methylation analysis in the new era of translational oncology : a focus on liquid biopsy", Biochim. Biophys. Acta Mol. Basis Dis, 1868, pp.166390~ (2022)
15. Song, C. -X., "5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages", Cell Res, 27, pp.1231~1242 (2017)
16. Loyfer, N., "A DNA methylation atlas of normal human cell types", Nature, 613, pp.355~364 (2023)
17. Barefoot, M. E., "Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment", JCI Insight, 8, pp.e156529~ (2023)
18. Klein, E. A., "Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set", Ann. Oncol, 32, pp.1167~1177 (2021)
19. Liu, M. C., "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA", Ann. Oncol, 31, pp.745~759 (2020)
20. Stackpole, M. L., "Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer", Nat. Commun, 13, pp.5566~ (2022)
21. Zhou, X., "Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis", Nat. Commun, 13, pp.7694~ (2022)
22. Chemi, F., "cfDNA methylome profiling for detection and subtyping of small cell lung cancers", Nat. Cancer (2022)[DOI]
23. Hu, X., "Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas", Nat. Commun, 12, pp.687~ (2021)
24. Shen, S. Y., "Sensitive tumour detection and classification using plasma cell-free DNA methylomes", Nature, 563, pp.579~583 (2018)
25. Liang, N., "Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning", Nat. Biomed. Eng, 5, pp.586~599 (2021)
26. Gao, Q., "Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing(THUNDER) : development and independent validation studies", Ann. Oncol (2023)[DOI]
27. Liu, Y., "At the dawn : cell-free DNA fragmentomics and gene regulation", Br. J. Cancer, 126, pp.379~390 (2022)
28. Thierry, A. R., "Circulating DNA fragmentomics and cancer screening", Cell Genomics, 3, pp.100242~ (2023)
29. Lo, Y. M. D., "Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies", Science, 372, pp.eaaw3616~ (2021)
30. Snyder, M. W., "Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin", Cell, 164, pp.57~68 (2016)
31. Cristiano, S., "Genome-wide cell-free DNA fragmentation in patients with cancer", Nature, 570, pp.385~389 (2019)
32. Esfahani, M. S., "Inferring gene expression from cell-free DNA fragmentation profiles", Nat. Biotechnol, 40, pp.585~597 (2022)
33. Zhou, X., "CRAG : de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing", Genome Med, 8, pp.138~ (2020)
34. Budhraja, K. K., "Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer", Sci. Transl. Med, 15, pp.eabm6863~ (2023)
35. Foda, Z. H., "Detecting liver cancer using cell-free DNA fragmentomes", Cancer Discov (2022)[DOI]
36. Mathios, D., "Detection and characterization of lung cancer using cell-free DNA fragmentomes", Nat. Commun, 12, pp.5060~ (2021)
37. Doebley, A. L., "A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA", Nat. Commun, 13, pp.7475~ (2022)
38. Siejka-Zielińska, P., "Cell-free DNA TAPS provides multimodal information for early cancer detection", Sci. Adv, 7, pp.eabh0534~ (2021)
39. Peneder, P., "Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden", Nat. Commun, 12, pp.3230~ (2021)
40. Jamshidi, A., "Evaluation of cell-free DNA approaches for multi-cancer early detection", Cancer Cell, 40, pp.1537~ (2022)
41. Vaisvila, R., "Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA", Genome Res, 31, pp.1280~1289 (2021)
42. Amin, M. B., "The Eighth Edition AJCC Cancer Staging Manual : continuing to build a bridge from a population-based to a more"personalized"approach to cancer staging : The Eighth Edition AJCC Cancer Staging Manual", CA Cancer J. Clin, 67, pp.93~99 (2017)
43. Chen, S., "fastp : an ultra-fast all-in-one FASTQ preprocessor", Bioinformatics, 34, pp.i884~i890 (2018)
44. Haoyu, C., "BitMapperBS: a fast and accurate read aligner for whole-genome bisulfite sequencing", bioRxiv, ~ (2018)
45. Danecek, P., "Twelve years of SAMtools and BCFtools", Gigascience, 10, pp.giab008~ (2021)
46. Van der Auwera, G. A., "From FastQ data to high-confidence variant calls : the genome analysis toolkit best practices pipeline", Curr. Protoc. Bioinformatics, 43, pp.11.10.1~11.10.33 (2013)
47. Amemiya, H. M., "The ENCODE blacklist : identification of problematic regions of the genome", Sci. Rep, 9, pp.9354~ (2019)
48. Gardiner-Garden, M., "CpG islands in vertebrate genomes", J. Mol. Biol, 196, pp.261~282 (1987)
49. Grossman, R. L., "Toward a shared vision for cancer genomic data", N. Engl. J. Med, 375, pp.1109~1112 (2016)
50. Ritchie, M. E., "limma powers differential expression analyses for RNA-sequencing and microarray studies", Nucleic Acids Res, 43, pp.e47~ (2015)
51. Heinz, S., "Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities", Mol. Cell, 38, pp.576~589 (2010)
52. Kuleshov, M. V., "Enrichr : a comprehensive gene set enrichment analysis web server 2016 update", Nucleic Acids Res, 44, pp.W90~W97 (2016)
53. Scheinin, I., "DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly", Genome Res, 24, pp.2022~2032 (2014)
54. Cancer Genome Atlas Research Network, "The Cancer Genome Atlas Pan-Cancer analysis project", Nat. Genet, 45, pp.1113~1120 (2013)
55. Ramírez, F., "deepTools2 : a next generation web server for deep-sequencing data analysis", Nucleic Acids Res, 44, pp.W160~W165 (2016)
56. Cortes, C., "Support-vector networks", Mach. Learn, 20, pp.273~297 (1995)
57. Thorvaldsdottir, H., "Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration", Brief. Bioinformatics, 14, pp.178~192 (2013)
58. McInnes, L., "UMAP : uniform manifold approximation and projection", J. Open Source Softw, 3, pp.861~ (2018)
59. Fabian, P., "Scikit-learn : machine learning in Python", J. Mach. Learn. Res, 12, pp.2825~2830 (2011)
60. Liu, H., "Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes", Nucleic Acids Res, 44, pp.75~94 (2016)
61. Beroukhim, R., "The landscape of somatic copy-number alteration across human cancers", Nature, 463, pp.899~905 (2010)
62. Steele, C. D., "Signatures of copy number alterations in human cancer", Nature, 606, pp.984~991 (2022)
63. Zack, T. I., "Pan-cancer patterns of somatic copy number alteration", Nat. Genet, 45, pp.1134~1140 (2013)
64. Alcaide, M., "Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR", Sci. Rep, 10, pp.12564~ (2020)
65. Pérez, R. F., "Aging and cancer epigenetics: where do the paths fork?", Aging Cell (2022)[DOI]
66. Renaud, G., "Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization", Elife, 11, pp.e71569~ (2022)
67. Chen, X., "Low-pass whole-genome sequencing of circulating cell-free DNA demonstrates dynamic changes in genomic copy number in a squamous lung cancer clinical cohort", Clin. Cancer Res, 25, pp.2254~2263 (2019)
68. Guo, S., "Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA", Nat. Genet, 49, pp.635~642 (2017)
69. Li, J., "DISMIR: deep learning-based noninvasive cancer detection by integrating DNA sequence and methylation information of individual cell-free DNA reads", Brief. Bioinformatics, 22, pp.bbab250~ (2021)
70. Li, W., "CancerDetector : ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data", Nucleic Acids Res, 46, pp.e89~e89 (2018)
71. Herbst, J., "Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions", Br. J. Cancer (2022)[DOI]
72. Poore, G. D., "Microbiome analyses of blood and tissues suggest cancer diagnostic approach", Nature, 579, pp.567~574 (2020)

관련 논문AI추천